Capital Advisors Ltd’s Integra LifeSciences IART Stock Holding History

Capital Advisors Ltd’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Buy	+122	New	+$1.71K	﹤0.01%	1123
2024 Q2	–	Sell	-12	Closed	–	–	1506
2024 Q1	$0	Buy	+12	New	+$480	﹤0.01%	1446
2023 Q3	–	Sell	-9	Closed	–	–	1366
2023 Q2	$0	Hold	9	–	–	﹤0.01%	1411
2023 Q1	$1K	Hold	9	–	–	﹤0.01%	1045
2022 Q4	$1K	Sell	9 -64	-88%	-$3.26K	﹤0.01%	1014
2022 Q3	$3K	Sell	73 -20	-22%	-$1.02K	﹤0.01%	747
2022 Q2	$5K	Hold	93	–	–	﹤0.01%	576
2022 Q1	$6K	Hold	93	–	–	﹤0.01%	569
2021 Q4	$6K	Buy	+93	New	+$6.29K	﹤0.01%	558

Other funds holding IART

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MAA

Mraz Amerine & Associates Modesto, California $697M AUM 19.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Capital Advisors Ltd's IART Position: Q2 2026 in Review

Capital Advisors Ltd opened a new position in Integra LifeSciences (IART) in Q2 2026: 122 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1123 among its holdings. This is a return to the name: Capital Advisors Ltd previously reported a position in IART as recently as Q1 2024.

Capital Advisors Ltd first reported a position in IART in Q4 2021 and has held it in 9 quarters since. The position peaked at $6K in Q1 2022. 16 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Capital Advisors Ltd held 122 shares of Integra LifeSciences worth $2K as of Q2 2026.
Integra LifeSciences was a new Capital Advisors Ltd position in Q2 2026.
Integra LifeSciences made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1123 holding.
Capital Advisors Ltd first reported a position in Integra LifeSciences in Q4 2021 and has held it in 9 quarters since.
Capital Advisors Ltd's Integra LifeSciences position peaked at $6K in Q1 2022.
16 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.